Heart rate variability biofeedback

Heart rate variability biofeedback has been studied in 7 papers since 2022: 4 trials in people, 2 reviews. The newest paper, Dec 3, 2024: “Heart Rate Variability, Hypnosis, and Psychotherapy”.

Intervention

7 papers study it2 findingsUpdated

See all 7 papers on heart rate variability biofeedback

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”
Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adultsScientific reports2023doi:10.1038/s41598-023-30167-0
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Institute on Aging and 1 more
  • Human trial4

What did studies of heart rate variability biofeedback find?

1

Studies of heart rate variability biofeedback measured one outcome, clinical outcomes in coronary heart disease, pain, and hypertension.

Clinical outcomes in coronary heart disease, pain, and hypertension

upin humans1

1 study
  1. Heart rate variability biofeedback improves clinical outcomes in coronary heart disease, pain, and hypertension in humans (coronary heart disease, pain, and hypertension).

    “Generally, the levels of evidence for the benefits of HRV-B is high in CHD, pain, and hypertension, moderate in cancer, and poor in diabetes and dementia.”

    Reviewcoronary heart disease, pain, and hypertension

    Neuromodulation Applied to Diseases: The Case of HRV Biofeedback

    Journal of clinical medicine

What is heart rate variability biofeedback linked with?

1

Studies link heart rate variability biofeedback with phosphorylated tau 181.

Phosphorylated tau 181

mixedin humans1

1 study
  1. Heart rate variability biofeedback is associated with phosphorylated tau 181 in humans.

    “There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”

    Human trial4 weeksn = 108

    Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adults

    Scientific reports

More on Phosphorylated tau 181

Latest